Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001596494-17-000002
Filing Date
2017-06-08
Accepted
2017-06-08 09:25:33
Documents
1
Effectiveness Date
2017-06-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8915
  Complete submission text file 0001596494-17-000002.txt   10080
Mailing Address 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA 19355 484-318-2988
Ralexar Therapeutics, Inc. (Filer) CIK: 0001596494 (see all company filings)

EIN.: 463970052 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-288286 | Film No.: 17899200